FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

5620411000001109: Capozide 25mg/50mg tablets (PI) (Dowelhurst Ltd) 20 tablet 2 x 10 tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
27512501000001113 Capozide 25mg/50mg tablets (PI) (Dowelhurst Ltd) 20 tablet 2 x 10 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
51867501000001117 Capozide 25mg/50mg tablets (Dowelhurst Ltd) 20 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Capozide 25mg/50mg tablets (PI) (Dowelhurst Ltd) 20 tablet 2 x 10 tablets Is a Co-zidocapt 25mg/50mg tablets 20 tablet true Inferred relationship Existential restriction modifier
Capozide 25mg/50mg tablets (PI) (Dowelhurst Ltd) 20 tablet 2 x 10 tablets Is pack of Capozide 25mg/50mg tablets (PI) (Dowelhurst Ltd) false Inferred relationship Existential restriction modifier
Capozide 25mg/50mg tablets (PI) (Dowelhurst Ltd) 20 tablet 2 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Capozide 25mg/50mg tablets (PI) (Dowelhurst Ltd) 20 tablet 2 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Capozide 25mg/50mg tablets (PI) (Dowelhurst Ltd) 20 tablet 2 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Capozide 25mg/50mg tablets (PI) (Dowelhurst Ltd) 20 tablet 2 x 10 tablets Has active ingredient Captopril false Inferred relationship Existential restriction modifier
Capozide 25mg/50mg tablets (PI) (Dowelhurst Ltd) 20 tablet 2 x 10 tablets Has active ingredient Hydrochlorothiazide false Inferred relationship Existential restriction modifier
Capozide 25mg/50mg tablets (PI) (Dowelhurst Ltd) 20 tablet 2 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Capozide 25mg/50mg tablets (PI) (Dowelhurst Ltd) 20 tablet 2 x 10 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Capozide 25mg/50mg tablets (PI) (Dowelhurst Ltd) 20 tablet 2 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Capozide 25mg/50mg tablets (PI) (Dowelhurst Ltd) 20 tablet 2 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Capozide 25mg/50mg tablets (PI) (Dowelhurst Ltd) 20 tablet 2 x 10 tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Capozide 25mg/50mg tablets (PI) (Dowelhurst Ltd) 20 tablet 2 x 10 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Capozide 25mg/50mg tablets (PI) (Dowelhurst Ltd) 20 tablet 2 x 10 tablets Has AMP Capozide 25mg/50mg tablets (PI) (Dowelhurst Ltd) true Inferred relationship Existential restriction modifier
Capozide 25mg/50mg tablets (PI) (Dowelhurst Ltd) 20 tablet 2 x 10 tablets Has specific active ingredient Captopril true Inferred relationship Existential restriction modifier
Capozide 25mg/50mg tablets (PI) (Dowelhurst Ltd) 20 tablet 2 x 10 tablets Has specific active ingredient Hydrochlorothiazide true Inferred relationship Existential restriction modifier
Capozide 25mg/50mg tablets (PI) (Dowelhurst Ltd) 20 tablet 2 x 10 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Capozide 25mg/50mg tablets (PI) (Dowelhurst Ltd) 20 tablet 2 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Capozide 25mg/50mg tablets (PI) (Dowelhurst Ltd) 20 tablet 2 x 10 tablets VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start